The initial clinical trial of a novel approach to treating amyotrophic lateral sclerosis -- blocking production of a mutant protein that causes an inherited form of the progressive neurodegererative disease -- may be a first step towards a new era in the treatment of such disorders.
Fuente : http://feeds.sciencedaily.com/~r/sciencedaily/~3/p...
Fuente : http://feeds.sciencedaily.com/~r/sciencedaily/~3/p...